Investment

Longevity Week London: Key quotes and articles

Last week was a big turning point in Longevity: In key centres of academic and scientific endeavour the key players in Longevity aligned. The three intense...

SENS’ Underdog launches novel CVD treatment

SENS Research Foundation launches Underdog - a new therapeutic approach to cardiovascular disease (CVD). According to the World Health Organisation (WHO), cardiovascular diseases is the...

Longevity Forum 2019 and the 150 year life

Leaders in the Longevity sector gather for annual Forum, with the message that people could soon be living up to 150 years. It’s the third...

First Longevity AI Consortium launched at King’s

UK launch at King's College of AI Longevity Hub has bold plans for 2020 and beyond. Kings College London was home to a landmark event...

Latest articles

CMS to invest £25m in UK start-ups

A collaboration between AstraZeneca, Cambridge Judge and Chinese pharmaceutical company CMS aims to close the funding gap for biotech and life sciences start-ups in...

AgeX and Lineage granted pluripotent patent

AgeX Therapeutics and Lineage Cell Therapeutics awarded U.S. patent for 'Method of Generating Induced Pluripotent Stem Cells'. AgeX Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. today announced...

Artificial neurons created on microchip

A major breakthrough for neural technology as scientists reproduce the electrical properties of neurons on a semiconductor chip. Researchers at Bath have made a world...

Longevity stocks: Go public with caution

SENS chief warns Longevity companies on perils of floating too soon. There is no doubt that the Longevity market is starting to take off. But...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.